Xencor Q1 2025 revenue rises to $32.7 million; net loss narrows to $48.4 million
Xencor reported first-quarter 2025 revenue of $32.7 million, up from $16.0 million a year earlier, and a net loss attributable to Xencor of $48.4 million, or $(0.66) per share, compared with a $73.4 million loss, or $(1.20) per share, in the prior-year quarter. The company also said chief development officer Nancy Valente will leave that role effective June 6, 2025, and remain as a senior advisor.
Key points
- Revenue was $32.7 million for the quarter ended March 31, 2025, versus $16.0 million a year earlier, mainly non-cash royalty revenue and milestone revenue from Incyte and Vir.
- Net loss attributable to Xencor narrowed to $48.4 million, or $(0.66) per share, from $73.4 million, or $(1.20) per share.
- R&D expenses rose to $58.6 million from $56.9 million, and G&A expenses rose to $17.3 million from $13.8 million.
- Cash, cash equivalents and marketable debt securities totaled $693.5 million at March 31, 2025, versus $706.7 million at December 31, 2024; the company expects to end 2025 with $535 million to $585 million.
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.